Adma Biologics stockADMA
Adma Biologics trades at $13.21, 35.4% below its 52-week high (Dec 12, 2025). The price is above its 50- and 200-day averages, i.e. in an uptrend. −27.6% year to date, −14.1% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Mar 25, 2027.
- Market pulseAdma Biologics posts Q3 2026 GAAP profit of $49.9M on $141.1M revenue, raises FY2026 adjusted net income and EBITDA outlooks
- Market pulseADMA Biologics gets constructive FDA pre-IND feedback for SG-001 pneumococcal hyperimmune globulin, eyes abbreviated registrational Phase 3 and IND filing
- GlobeNewswireADMA Biologics Reports Third Quarter 2026 Financial Results and Provides Business Update
The trigger was the quarterly report: EPS +41% year over year, 14.5% above the estimate.
All moves of the day →Ratings, candles, signals and the screener for ADMA — after you log in
Open the terminalFrequently asked questions about Adma Biologics
What is the Adma Biologics stock price?
At the close on Nov 5, 2026: $13.21 (+26.05% on the day). 52-week high: $20.46 on Dec 12, 2025. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Adma Biologics report earnings?
The next quarterly report is on Mar 25, 2027. Last quarter, earnings per share changed +41% year over year, revenue +5%.
Does Adma Biologics pay dividends?
No, Adma Biologics does not pay dividends.
Where does Adma Biologics trade and how to buy it?
Ticker ADMA, exchange Nasdaq. You can buy it through a broker with access to US exchanges.
Should I buy Adma Biologics now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for ADMA are in the terminal after you log in.